Xeris Biopharma Holdings, Inc. (XERS)

6.195 +0.12 (+2.06%) USD  |  NASDAQ  |  Apr 15, 16:00
6.195 0.00 (0.00%) After-Hours: 20:00
More

Xeris Biopharma Holdings Research and Development Expense (Annual) : 31.16M for Dec. 31, 2025

Research and Development Expense (Annual) Chart

View Research and Development Expense (Annual) for XERS.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00
View Research and Development Expense (Annual) Chart
Start Trial

Historical Data

View Historical Data
Start Trial

R&D Expense Definition

View R&D Expense Definition
Start Trial

R&D expense is a line item from many companies' income statements.

Read full definition.

Research and Development Expense (Annual) Range, Past 5 Years

View Research and Development Expense (Annual) Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

Research and Development Expense (Annual) Benchmarks

View Research and Development Expense (Annual) Benchmarks
Start Trial
IDEXX Laboratories, Inc. 251.21M
Zoetis, Inc. 698.00M
Harrow, Inc. 12.85M
Zymeworks, Inc. 137.00M
Vir Biotechnology, Inc. 432.80M